Price T Rowe Associates Inc Procept Bio Robotics Corp Transaction History
Price T Rowe Associates Inc
- $883 Billion
- Q2 2025
A detailed history of Price T Rowe Associates Inc transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,322,439 shares of PRCT stock, worth $49.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,322,439
Previous 1,055,762
25.26%
Holding current value
$49.1 Million
Previous $61.5 Million
23.84%
% of portfolio
0.01%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding PRCT
# of Institutions
293Shares Held
44MCall Options Held
236KPut Options Held
91.9K-
Vanguard Group Inc Valley Forge, PA5.25MShares$195 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$129 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.16MShares$80.1 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.53MShares$56.7 Million0.06% of portfolio
-
Geode Capital Management, LLC Boston, MA1.3MShares$48.2 Million0.01% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.66B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...